↓ Skip to main content

Clinical development and marketing application review times for novel orphan-designated drugs

Overview of attention for article published in Frontiers in Medicine, June 2024
Altmetric Badge

Mentioned by

twitter
1 X user
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Clinical development and marketing application review times for novel orphan-designated drugs
Published in
Frontiers in Medicine, June 2024
DOI 10.3389/fmed.2024.1404922
Pubmed ID
Authors

Ebru Demirci, Jennifer Knicley, Lori Fiorentino

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 June 2024.
All research outputs
#21,328,996
of 26,180,352 outputs
Outputs from Frontiers in Medicine
#5,230
of 7,432 outputs
Outputs of similar age
#142,035
of 213,568 outputs
Outputs of similar age from Frontiers in Medicine
#49
of 76 outputs
Altmetric has tracked 26,180,352 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,432 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.1. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 213,568 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 76 others from the same source and published within six weeks on either side of this one. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.